Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aurora Cannabis

Cronos Group

HEXO Corp

Tilray Brands

With talk of a looming recession, analysts predict that given a downturn there will be a short list of growth industries capable of delivering a healthy return on investment.

5 Key Factors To Consider Before Making A Cannabis Acquisition

Aphria

CannTrust Holdings

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

GW Pharmaceuticals

Amplify Alternative Harvest ETF

Scotts Miracle-Gro

The week brought big cannabis news, with the FDA setting its first hearing regarding CBD's legality in food and drinks for May, and the STATES Act, which aims to protect cannabis businesses and users in legal states from federal intervention, being introduced in Congress.

This Week's Cannabis News: The FDA And CBD, The STATES Act, Cresco And Origin House, Europe And High Times

Despite signs of a slowdown, Constellation Brands' CEO is still confident about blazing fast sales growth from his company's new partner.

Can Canopy Growth Sales Reach $1 Billion This Year?

Some very large transactions have sparked the cannabis sector lately, and I expect to see a lot more of this in the months ahead

Mergers And Acquisitions Light Up The Cannabis Sector

Consolidation and equity investments are picking up steam as the green rush takes shape.

The 5 Largest Marijuana Deals in History

Hint: It's not the biggest of the big players.

Which Big Canadian Marijuana Stock Has the Most Upside Potential Right Now?

Sales are soaring, but so are operating losses for most pot stocks.

Marijuana Stock Earnings: A Comprehensive Look at First-Quarter Results

It's the marijuana industry equivalent of David vs. Goliath. But can the giant win this matchup?

Better Buy: Organigram Holdings (OGRMF) vs. Canopy Growth (CGC)

Axon Enterprise

NextEra Energy

College costs are rising and so are these stocks.

Three Stocks That Could Help You Send Your Kids to College

Neptune Wellness Solutions Inc.

Shares of Canopy Growth's cannabis extraction partner are up more than 30% in 2019, despite their pullback last month.

Why Marijuana Stock Neptune Wellness Fell 12.1% in March

Despite Canopy being the largest pot stock in the world, plenty of its peers offer much better value.

Forget Canopy Growth: These Pot Stocks Are Much More Attractive

Constellation Brands

Jim Cramer catches up with Constellation CEO Bill Newlands after the company's latest earnings report and gets insight on the future of cannabis.

Canopy can generate $1 billion in revenue this fiscal year, Constellation CEO says

Cronos is the new third-largest pot stock, but it has no business being listed side by side with its larger peers.

Cronos Group Can't Hold a Candle to Aurora Cannabis or Canopy Growth

A ranking of the top marijuana growers by sales in the most recent quarter.

Here's Who Sold the Most Marijuana Last Quarter

The beer, wine, and spirits distributor also confirmed it would sell part of its wine business for $1.7 billion.

Constellation Brands Posts a Solid Q4, and Pivots Toward Growth

Wall Street weighs in on the largest pot stock in the world.

Here's How Much Revenue Canopy Growth Will Generate in 2022

The big Canadian marijuana stock dominated in the first quarter for three main reasons.

Why Aurora Cannabis Outperformed Canopy Growth and Tilray in Q1

The company has suffered from slowing beer and wine sales as its marijuana investment stumbles.

Beyond Pot, What Constellation Brands Investors Should Look for in Q4

An industry worth $910 million in 2015 reached $13.8 billion in 2018, and it seems bound only sunward yet: The bottom line is, the sky’s the limit.

For Cannabis Industry Investment, 2018 Was Terrific But 2019 Looks Even Better

Both are tapped into a growing market for cannabis, but which stock is the better pick right now?

Better Marijuana Stock: Canopy Growth vs. Scotts Miracle-Gro

Two leaders, two laggards, and one in the group of top marijuana stocks that's most likely to succeed in the States.

Which Canadian Marijuana Stock Is Best Poised to Win in the U.S.: Aurora Cannabis, Cronos, Canopy Growth, or Tilray?

Canopy Growth is big. And its stock is soaring.

Looking to Buy Canopy Growth? Here Are 5 Things You Should Know First

The results are in -- and it's clear who the winners are so far in Canada's recreational marijuana market.

Canadian Recreational Pot Market: How the Big 5 Marijuana Growers Compare

If you think it'll be up, up, and away for pot stocks, you're probably in for an unpleasant surprise.

5 Off-the-Cuff Thoughts About the Marijuana Industry

It’s that time again. The Benzinga Events team is busy planning for the third Cannabis Capital Conference back in one of our favorite spots and the heart of the cannabis industry—Toronto.

News for Canopy Growth Stock (CGC)